TPMT and Decreased total leukocyte count: The effect of TPMT genotype-guided thiopurine administration on hematologic adverse drug reactions, such as leukopenia and thrombocytopenia, between genotyped and non-genotyped arms was not significantly different (frequency: 7.4% versus 7.9%; relative risk: 0.93).